SeekingAlpha · Jan 21, 2026
Cedar Creek Partners Q4 2025 Expert Market Exposure
Cedar Creek Partners details high-alpha returns in the expert market via positions like Exco Resources and Phi Group. Read the full analysis for deep value picks.
PD
OTC · PDRX
PD-Rx Pharmaceuticals, Inc.
Healthcare · Medical - Distribution
$3.35
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 1:31 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.8M
- P/E ratio
- -6.11
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 250
- Avg. volume
- 64
Price performance
PDRX price history
1M range · 0 trading sessions · Daily adjusted prices
PDRX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PDRX news
The latest Smart Investors Daily articles mentioning PDRX.
Stock researchCompany · Overview
PDRX research
Overview
Company profile and research snapshot.
Company profile
PD-RX PHARMACEUTICALS INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
